These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2475051)

  • 1. Sensitivity of multidrug resistant KB-C1 cells to an antibody-dextran-adriamycin conjugate.
    Sheldon K; Marks A; Baumal R
    Anticancer Res; 1989; 9(3):637-41. PubMed ID: 2475051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.
    Shouval D; Adler R; Wands JR; Hurwitz E; Isselbacher KJ; Sela M
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8276-80. PubMed ID: 2460865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-human IgG-dextran-adriamycin conjugate for immunotargeting of S180 sarcoma: effects on the tumor weight and survival time of the tumor-bearing mice].
    Zhang J; Luo M; Zhou Y; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):646-8. PubMed ID: 18495611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anti-alpha-fetoprotein-adriamycin conjugate on a human hepatoma.
    Galun E; Shouval D; Adler R; Shahaar M; Wilchek M; Hurwitz E; Sela M
    Hepatology; 1990 Apr; 11(4):578-84. PubMed ID: 1691730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer.
    Yu DS; Chu TM; Yeh MY; Chang SY; Ma CP; Han SH
    J Urol; 1988 Aug; 140(2):415-21. PubMed ID: 3398165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and DNA binding of dextran-doxorubicin conjugates in multidrug-resistant KB-V1 cells: optimization of dextran size.
    Lam W; Leung CH; Chan HL; Fong WF
    Anticancer Drugs; 2000 Jun; 11(5):377-84. PubMed ID: 10912954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
    Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.
    Shiraishi N; Akiyama S; Nakagawa M; Kobayashi M; Kuwano M
    Cancer Res; 1987 May; 47(9):2413-6. PubMed ID: 3567927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells.
    Fritzer M; Szekeres T; Szüts V; Jarayam HN; Goldenberg H
    Biochem Pharmacol; 1996 Feb; 51(4):489-93. PubMed ID: 8619895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor.
    Aboud-Pirak E; Hurwitz E; Bellot F; Schlessinger J; Sela M
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3778-81. PubMed ID: 2786202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in protein kinase C subspecies protein expression and activity in a series of multidrug-resistant human KB carcinoma cell lines.
    Drew L; Groome N; Hallam TJ; Warr JR; Rumsby MG
    Oncol Res; 1994; 6(9):429-38. PubMed ID: 7703529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
    Recht LD; Griffin TW; Raso V; Salimi AR
    Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody.
    Fukumoto H; Nishio K; Ohta S; Hanai N; Saijo N
    Int J Cancer; 1996 Sep; 67(5):676-80. PubMed ID: 8782657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic effect of adriamycin-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T; Chu TM; Leong SS; Horozsewicz JS; Lee CL
    J Urol; 1987 Feb; 137(2):353-8. PubMed ID: 3806841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
    Morimoto H; Yonehara S; Bonavida B
    Cancer Res; 1993 Jun; 53(11):2591-6. PubMed ID: 7684321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.
    Laske DW; Ilercil O; Akbasak A; Youle RJ; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):520-6. PubMed ID: 8113865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R
    Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.
    Lyall RM; Hwang JL; Cardarelli C; FitzGerald D; Akiyama S; Gottesman MM; Pastan I
    Cancer Res; 1987 Jun; 47(11):2961-6. PubMed ID: 3494506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti cancer effect of antibiotic-AFP-purified antibody conjugates].
    Tsukada Y; Hibi N; Ohkawa K; Uchino J; Hirai H
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2653-8. PubMed ID: 6210058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.